The interest in targeting the PI3K/mTOR pathway as a therapeutic strategy is remarkably increasing, in particular after the recent finding that the dormant state entered by some cancer cells as a result of stress-inducing factors is very similar to diapause, the mechanism used by ESCs to survive harsh microenvironmental conditions [3,4]. Here, MTOR is linked to cancer.